Please login to the form below

Not currently logged in
Email:
Password:

pharma acquisition

This page shows the latest pharma acquisition news and features for those working in and with pharma, biotech and healthcare.

Sanofi completes acquisition of immuno-oncology specialist Synthorx

Sanofi completes acquisition of immuno-oncology specialist Synthorx

Hudson took the helm at Sanofi from Olivier Brandicourt last September, and the Synthorx acquisition was his first major play as CEO. ... In addition to orchestrating his first acquisition, Hudson had reportedly been considering options to sell the

Latest news

  • Galen completes acquisition of healthcare company POA Pharma Galen completes acquisition of healthcare company POA Pharma

    Global pharmaceutical sales and marketing company Galen has completed a multi-million pound acquisition of healthcare company POA Pharma. . ... POA Pharma is headquartered in Sweden and has further facilities in the Nordic region and North America.

  • Dassault Systèmes completes acquisition of Medidata Dassault Systèmes completes acquisition of Medidata

    Medidata will now operate as a separate brand of DS. Dassault Systèmes has completed the acquisition of Medidata,  a digital clinical solutions company with a leading clinical trial platform. . ... The acquisition of Medidata will provide Dassault

  • Gilead promotes Andrew Dickinson to CFO, increased M&A expected Gilead promotes Andrew Dickinson to CFO, increased M&A expected

    Dickinson helmed company’s acquisition of Kite and partnership with Galapagos. Andrew Dickinson has been selected as Gilead's new chief financial officer – as the pharma giant looks to expand outside ... During his time at Gilead, Dickinson oversaw

  • Pfizer adds Array to cancer arsenal with $11bn acquisition Pfizer adds Array to cancer arsenal with $11bn acquisition

    The acquisition announced yesterday is the big pharma company's largest since it bought another oncology specialist, Medivation in 2016 for $14bn, and could help build a third cancer blockbuster franchise ... Analysts at Evaluate Pharma forecast

  • Roche buys gene therapy specialist Spark for $4.3bn Roche buys gene therapy specialist Spark for $4.3bn

    The acquisition will inevitably increase expectation of more buyouts in the cell and gene therapy sector. ... It is awaiting an EMA review of its LentiGlobin candidate, expected later this year, but would also be high on big pharma acquisition lists

More from news
Approximately 10 fully matching, plus 83 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Acquisition. $244m. Zealand/. Royalty Pharma. Royalty streams and milestones for Soliqua 100/33/. ... So two opportunities here – acquisition of animal health products and out-licensing to Bayer’s pharma business.

  • The good, the bad and the ugly The good, the bad and the ugly

    The company hopes its $12bn acquisition of Kite Pharma (August 2017) will help it steal a march on the lucrative CAR-T market through its treatment for advanced lymphoma. ... The data this article was based on is available in full online:

  • Pharma deals continue to slide Pharma deals continue to slide

    Given big pharma’s reluctance to spend on M&A it is perhaps surprising that this month Gilead has announced the $11.9bn acquisition of Kite Pharma. ... 175+ (upfront 75). Weifa (NO). Karo Pharma (SE). Company acquisition. Karo acquires Norwegian OTC

  • Deal Watch - May 2017 Deal Watch - May 2017

    Stada (pharma). 4, 350. Apax. Company acquisition. Syneron (aesthetic devices). 397. ... Gurnet Point. Company acquisition. Innocoll (pharma). 209. Capital International. Minority share.

  • Deal Watch February 2017 Deal Watch February 2017

    Other pharma companies divesting assets this month include Janssen/J&J and Sanofi. ... It is apparently eyeing a potential acquisition of the CRO PPD for around $8bn.

More from intelligence
Approximately 0 fully matching, plus 36 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Mergers and acquisitions: agents for change

    Getting the best from your agency in a disruptive time. Multi-billion dollar mergers and acquisitions have always created headlines in pharma news, and it’s fair to say that the ... We have supported clients in the run up to the merger or acquisition

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...

Infographics